![](https://images.thewest.com.au/publication/C-15308144/6415295ecaab2098e3d6b0193a6c2e0ebe5b3b4c-16x9-x0y92w1440h810.jpg?imwidth=1200)
Radiopharm unveils landmark human lung cancer trial
Radiopharm Theranostics has kicked off the first phase of clinical trials testing its “RAD 204” treatment aimed at beating the most common type of lung cancer – non-small cell lung cancer (NSCLC) – after dosing its first patient in New South Wales. The …